Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 2 DiabetesGenetics of DiabetesIssue 729

Circulating MicroRNAs Associated with Type 2 Diabetes

Researchers identified increases in three miRNAs and decreases in seven miRNAs in patients with type 2 diabetes…. 

Advertisement

Francisco J. Ortega, Ph.D., and colleagues from the Institut d'Investagacio Biomedica de Girona in Spain studied circulating miRNA in 12 men, six of whom had normal glucose tolerance and the other six who had type 2 diabetes. The association of 10 circulating miRNAs with type 2 diabetes was also verified cross-sectionally in another sample of 45 men with normal glucose tolerance and 48 men with type 2 diabetes. A longitudinal validation was carried out in 35 patients with type 2 diabetes in a randomized, three month long metformin trial. Furthermore, circulating miRNAs were studied in seven healthy participants before and after a six hour hyperinsulinemic-euglycemic clamp and insulin plus intralipid/heparin infusion.

Researchers identified increases in three miRNAs and decreases in seven miRNAs in patients with type 2 diabetes. They found that miR-140-5p and miR-423-5p independently accounted for 49.5% of fasting glucose variance after controlling for confounders. These two specific miRNAs along with miR-195 and miR-126 were specific for type 2 diabetes with 89.2% accuracy. Significant reduction in fasting glucose, glycated hemoglobin, and changes in circulating miR-192, miR-140-5p, and miR-22 were seen with metformin but not placebo. Reduction in miR-222 was seen with insulin infusion during clamp, while increases in circulating miR-222 and miR-140-5p were seen with the intralipid/heparin mixture. These results show that there is a close association between circulating miRNAs and type 2 diabetes.

Practice Pearls:
  • Levels of circulating miRNAs vary with insulin action
  • There is an association between circulating miRNAs and type 2 diabetes as they may play a potentially important role in insulin sensitivity

"Circulating MicroRNAs Linked to Type 2 Diabetes."  http://www.ncbi.nlm.nih.gov/pubmed/24478399

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  Type 2 DiabetesGenetics of DiabetesIssue 729

Past five issues: Diabetes Clinical Mastery Series Issue 241 | issue 781 | Diabetes Clinical Mastery Series Issue 240 | Issue 780 | Diabetes Clinical Mastery Series Issue 239 |

2015 Most Popular Articles:

Neuropathy Due to Vitamin B-12 Deficiency, Not Diabetes
Posted April 30, 2015
What Is the Medicare Diabetes Prevention Act?
Posted May 08, 2015
Statin Therapy Associated with 46% Higher Risk of Type 2 Diabetes
Posted April 23, 2015
Metformin Reported in Use with Only 3.7% of Those with Prediabetes
Posted April 30, 2015
Is Diet or Exercise the Best Way to Reduce Diabetes Risk?
Posted May 15, 2015
FDA Panel Recommends New CV Safety Warnings on Onglyza and Nesina DPP-4s
Posted April 17, 2015
Summary of Standards of Care for Diabetes for Primary Care
Posted April 30, 2015
SGLT-2 Inhibitors: Teach from the Start and Manage Expectations
Posted May 03, 2015
Relationship between Consumption of Protein, Carbs and Long-Term Weight Gain
Posted April 23, 2015
Oral Insulin May Prevent Type 1 Diabetes in High-Risk Children
Posted April 23, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you believe that we could have a bionic pancreas by 2017?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control